The Schengen certificate for medication, explained

The Schengen certificate for medication is a single-purpose document. It exists so that a patient prescribed a controlled medicine can carry that medicine across an internal Schengen border without the carriage being treated as drug trafficking. Its legal basis is Article 75 of the Convention implementing the Schengen Agreement, which is why national health authorities also call it the Article 75 certificate or, in German, the Schengen-Bescheinigung.

Three things it is not, stated up front, because each one sends people down the wrong path.

• It is not a general permit for medicines. Ordinary prescription medicines, blood-pressure tablets, statins, thyroid medication, asthma inhalers, do not need one. The certificate is for medicines classed as narcotic or psychotropic under national controlled-substances law.
• It is not a travel document for arriving from outside the Schengen Area. It governs movement between Schengen states. A flight from the United States or the United Kingdom into Europe is a different question, covered further down.
• It is not a residence solution. Its maximum validity is 30 days. Nothing about it makes a foreign prescription renewable in Europe.

Which medicines are involved varies by country, because each state schedules its own controlled substances. In practice the recurring categories are opioid painkillers, stimulants prescribed for attention disorders, benzodiazepines, strong sleeping medicines and opioid substitution treatments. The French medicines agency ANSM names buprenorphine, fentanyl, hydromorphone, methadone, methylphenidate, morphine and oxycodone as examples on its page for patients travelling with their medicines, which carried a last-updated date of 29 May 2026 when we read it on 7 August 2026. If you are not sure whether one of your medicines is on your country's list, ask the prescriber before you assume it is not.

The certificate follows the same four-step shape in every country that issues it, even though the office you deal with changes.

• Your prescribing doctor completes the form. The Schengen form is a standard layout carrying the patient's identity, the medicine, the active substance, the single and daily dose and the period of travel.
• A public health authority authenticates it. This is the step people miss. A doctor's signature alone is not the certificate. A designated authority has to certify the form, and it has to happen before the journey begins.
• One certificate per controlled medicine. BfArM, Germany's Federal Institute for Drugs and Medical Devices, states on its page about travelling with narcotic drugs that a separate certificate is required for each prescribed controlled drug. Two controlled medicines means two certificates.
• It expires. BfArM states the certificate is valid for a maximum of 30 days.

Alongside the certificate, the medicines themselves should stay in their original dispensing packaging with the label attached, and the patient should carry them personally. The Austrian health ministry is explicit that controlled substances may only be taken for your own use and that you cannot have someone else carry them for you.

Two planning points follow from the mechanics. The authentication step involves a public office with its own processing time, so this is not a document you obtain the week you fly. And because validity is capped at 30 days, a certificate obtained for a house-hunting trip in March does nothing for the move in June.

Germany publishes the clearest official English explanation of the whole instrument, which is why it is worth reading even if you are moving elsewhere. BfArM, the Federal Institute for Drugs and Medical Devices, runs the Federal Opium Agency (Bundesopiumstelle) and sets out the rules on its page about travelling with narcotic drugs.

What that page states, as read on 7 August 2026:

• The certificate is completed by the treating physician.
• It must be authenticated by the competent supreme health authority of the Land, or by an authority authorised to perform that task, before the journey begins. In other words the certifying body is the state health ministry where you live, not BfArM itself, and not your local doctor's surgery.
• It is valid for a maximum of 30 days.
• A separate certificate is required for each prescribed controlled drug.

Because Germany is a federal state, the office that authenticates the form differs by Land, so the practical first move is to ask the prescribing practice which authority they submit to. The form itself is published by BfArM, so the doctor is usually working from a document they have seen before.

For destinations outside the Schengen Area, BfArM points travellers to the guidance published by the International Narcotics Control Board rather than to the Schengen form, and the INCB general information for travellers describes a multilingual certificate from the prescribing doctor giving dosage and duration, authenticated by the appropriate health authority. That is the correct route for, say, a trip from Germany to the United States, and it is not the same document.

The Article 75 spine is shared, but the office you deal with is national, and in two of these three countries the paperwork is not even called the same thing.

Austria. The Federal Ministry of Social Affairs, Health, Care and Consumer Protection states on its page about taking medication abroad, last updated 15 October 2019, that the Schengen form is used, that it is filled in by the prescribing doctor, and that it is certified by the medical officer (Amtsarzt) at the district authority responsible for your main residence, meaning the Magistrat in a city or the Bezirkshauptmannschaft elsewhere. Validity is up to 30 days of travel. The same page states that addictive substances may only be taken with you for your own use.

France. France splits the job in two, which surprises people. On its patient page Voyager avec mes médicaments, last updated 29 May 2026, ANSM states that for travel within Schengen countries the patient should contact the agence régionale de santé (regional health agency) of the region where the prescribing doctor is registered, in order to obtain the attestation. For travel outside Schengen, ANSM is itself the competent authority issuing the transport certificate, and it asks for the request to be made a minimum of ten days before departure through an online form with a scanned copy of the prescription. ANSM also states that certificates cover a quantity corresponding to a treatment duration not exceeding the maximum authorised prescription duration of 28 days, or 14 days for methadone syrup. And for entering France, the same page states that no personal transport attestation is required, but that you must carry the original of your prescription.

Spain. The Spanish medicines agency AEMPS states, on its page for medicines intended for the treatment of travellers last updated 28 May 2026, that a traveller's maximum quantity of medicine must be appropriate to the prescribed treatment and should not exceed the amount needed for three months of treatment, and that a prescription or medical report may be required both on entry to and on exit from Spain. For narcotics and psychotropics, AEMPS states on that page that travellers entering Spain must request permission from the Área de Estupefacientes y Psicótropos of its Department of Inspection and Control of Medicines, while travellers leaving Spain obtain a transport certificate. That AEMPS page does not use the Schengen certificate label for the inbound case, so follow the route the agency itself describes and confirm your own case with AEMPS before you travel.

We would rather tell you where the trail goes cold than fill the gap with something plausible, because a wrong answer here is the kind that gets a medicine confiscated.

Italy. The operative instrument for travellers carrying medicines based on narcotic or psychotropic substances for their own therapeutic use is a Ministry of Health decree of 16 November 2007. The Ministry of Health website served an automated browser-validation interstitial on every attempt to read its English travellers' page on 4 and 7 August 2026, so we have not re-derived the decree's requirements from the Ministry's own wording and are not going to summarise them from anywhere else. Verify with the Italian Ministry of Health or AIFA, the Italian Medicines Agency, before travelling with a controlled medicine.

Portugal. INFARMED, the national medicines authority, publishes a controlled substances page and is the competent authority for import, export and transit authorisations for controlled substances. Checked on 4 and 7 August 2026, we did not find traveller-facing guidance stating a personal-quantity limit or a Schengen certificate procedure on that page, on INFARMED's import page, or on the SNS 24 traveller's kit. That is an absence on those pages only. Ask INFARMED directly.

Greece. Checked on 4 August 2026, we found an official import-approval service record for medicines from foreign countries on the Greek government services portal, but no traveller-facing narcotic or psychotropic carriage guidance on the EOPYY cross-border health pages, the national travel portal or the Ministry of Health site. Scoped to those three, that is a gap rather than a rule. Verify with the National Organisation for Medicines (EOF).

Malta. The Malta Medicines Authority site could not be read in either research pass, so we make no claim at all about Maltese requirements. Verify with the Malta Medicines Authority.

Where a national page is silent, the safest working assumption is not that there is no rule. It is that the rule exists and you have not found it, which is a good reason to email the authority rather than rely on a search result.

This is the single most common misunderstanding in relocation advice, so it is worth its own heading.

An American or British family flying into Europe is not making an internal Schengen journey. The Article 75 certificate governs movement between Schengen states, and the authority that authenticates it is the health authority where the prescribing doctor sits. If your prescriber is in Ohio or Yorkshire, there is no Schengen health authority in the chain.

Two separate legs, then, and each has its own paperwork.

• Leaving. The United Kingdom operates a personal-licence regime for travelling with lawfully prescribed controlled drugs above a threshold, with a prescriber's letter used below it. Check the current GOV.UK guidance on controlled drugs and personal licences for your own quantities before you fly.
• Arriving. The destination country's customs and medicines rules apply. Those are national, they differ, and they are the ones set out per country above.

What travels well on both legs is a multilingual prescriber's certificate. The INCB guidance for travellers describes exactly that document, giving the international name of the active substance, the single and daily dose and the duration of travel, authenticated by the appropriate health authority. BfArM points travellers to the same INCB guidance for journeys outside Schengen. It is not a Schengen certificate, but it is the nearest universally recognised equivalent and it is what a customs officer anywhere is best placed to read.

Carry the medicines in original packaging with the dispensing label attached, keep them in hand luggage, and keep the letter with them rather than in a case that can be delayed.

Come back to the 30-day cap, because it settles the question a relocating family actually has.

A certificate valid for a maximum of 30 days is designed for a person travelling with their treatment. It is not designed for a person who has moved and needs the same medicine every month for years. So the plan for a move has two stages, and the second one is the one that gets underestimated.

Stage one is carrying a lawful supply in, with the national paperwork for your destination. Stage two is getting the medicine re-prescribed by a doctor practising in your new country before that supply runs out. For a controlled medicine, stage two takes longer than people expect, because a prescriber taking over someone else's controlled prescription will want the diagnosis, the treatment history and usually their own assessment first. Work backwards from the date your carried supply ends, allow for registering with the local health system and finding a doctor accepting new patients, and start in your first fortnight rather than your last.

Private medical cover matters in exactly that window. For visa-holders and new arrivals, public entitlement usually starts some time after landing, and in some countries considerably later. Cover arranged for a residence application or for a first period abroad is designed to carry outpatient consultations and prescribed medicines while the public position is being established, which is what lets you get in front of a doctor and have the medicine re-prescribed rather than rationing what you carried.

Three limits worth being blunt about. No policy changes what you may lawfully carry across a border, so the certificate and customs paperwork still have to be done. No policy obliges a doctor to continue a treatment started abroad, because that is a clinical judgement. And what is payable is whatever the policy wording says, so read the outpatient and prescribed-medicines sections and the claims route when you buy rather than at a pharmacy counter.